epichlorohydrin has been researched along with Hypercholesterolemia in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (66.67) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoyama, J; Futami-Suda, S; Hashimoto, M; Igari, Y; Kigawa, Y; Nakano, H; Oba, K; Suzuki, T; Tsunoda-Kubota, M; Watanabe, K | 1 |
Hansen, M; Knop, FK; Sonne, DP | 1 |
Arakawa, H; Idota, Y; Kakinuma, C; Kasahara, F; Kato, T; Kobayashi, S; Kogure, Y; Miyajima, C; Ogawa, M; Ogihara, T; Yano, K | 1 |
Kadonosono, K; Kaneko, T; Kawaguchi, J; Morita, S; Shigematu, E; Terauchi, Y; Yamakawa, T | 1 |
Daida, H; Miyauchi, K; Shimada, K | 1 |
Fukami, K; Haramaki, N; Iida, S; Ikeda, H; Imaizumi, T; Matsuoka, H; Murase, E; Sugano, R; Umei, H | 1 |
Kadonosono, K; Okamura, A; Takano, T; Utsunomiya, H; Yamakawa, T | 1 |
Futami, S; Igari, Y; Kigawa, Y; Matsumura, N; Nakano, H; Oba, K; Ouchi, M; Suzuki, K; Suzuki, T; Watanabe, K | 1 |
Haramaki, N; Ikeda, H; Imaizumi, T; Katoh, A; Matsuoka, H; Sugano, R; Takenaka, K; Yamagishi, S | 1 |
Futami-Suda, S; Igari, Y; Kigawa, Y; Matsumura, N; Nakano, H; Oba, K; Ouchi, M; Suzuki, K; Suzuki, T; Watanabe, K | 1 |
Futami-Suda, S; Igari, Y; Kigawa, Y; Matsumura, N; Nakano, H; Oba, K; Ouchi, M; Suzuki, K; Suzuki, T; Watanabe, K; Yasuoka, H | 1 |
Futami-Suda, S; Kigawa, Y; Nakano, H; Norose, J; Oba, K; Ouchi, M; Sekimizu, K; Suzuki, K; Suzuki, T; Yoshimatsu, H | 1 |
1 review(s) available for epichlorohydrin and Hypercholesterolemia
Article | Year |
---|---|
Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes.
Topics: Bile Acids and Salts; Blood Glucose; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Gastric Emptying; Glycated Hemoglobin; Humans; Hypercholesterolemia; Hypoglycemic Agents; Imidazoles; Incretins; Lipid Metabolism; Male; Resins, Synthetic; Signal Transduction; Treatment Outcome | 2014 |
4 trial(s) available for epichlorohydrin and Hypercholesterolemia
Article | Year |
---|---|
Polymorphonuclear leukocytes may impair endothelial function: results of crossover randomized study of lipid-lowering therapies.
Topics: Anticholesteremic Agents; Atherosclerosis; Cell Adhesion; Cholesterol, LDL; Cross-Over Studies; Endothelium, Vascular; Epichlorohydrin; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hypercholesterolemia; Imidazoles; Indoles; Lipoproteins, LDL; Male; Middle Aged; Neutrophils; Nitric Oxide Synthase Type III; Phosphorylation; Resins, Synthetic; Serine; Superoxides; Vasodilation | 2005 |
Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia.
Topics: Aged; Anticholesteremic Agents; Blood Glucose; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Glycated Hemoglobin; Hemoglobins; Humans; Hypercholesterolemia; Imidazoles; Insulin Resistance; Male; Middle Aged; Pravastatin; Resins, Synthetic | 2007 |
Blood glucose-lowering activity of colestimide in patients with type 2 diabetes and hypercholesterolemia: a case-control study comparing colestimide with acarbose.
Topics: Acarbose; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Glycoside Hydrolase Inhibitors; Humans; Hypercholesterolemia; Hypoglycemic Agents; Imidazoles; Lipids; Male; Resins, Synthetic | 2006 |
Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase.
Topics: Adult; Anion Exchange Resins; Blood Platelets; Cholesterol; Cross-Over Studies; Dose-Response Relationship, Drug; Epichlorohydrin; Fatty Acids, Monounsaturated; Female; Fluvastatin; Glutathione; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Imidazoles; Indoles; Male; Middle Aged; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Platelet Aggregation; Polyisoprenyl Phosphates; Prospective Studies; Resins, Synthetic; Treatment Outcome; Triglycerides; Tyrosine | 2007 |
7 other study(ies) available for epichlorohydrin and Hypercholesterolemia
Article | Year |
---|---|
What characteristics at baseline are associated with the glucose-lowering effect of colestimide in patients with type 2 diabetes and hypercholesterolemia according to response to treatment?
Topics: Aged; Blood Glucose; Body Mass Index; Cholelithiasis; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Glycated Hemoglobin; Humans; Hypercholesterolemia; Hypoglycemic Agents; Imidazoles; Male; Middle Aged; Pilot Projects; Regression Analysis; Resins, Synthetic; Time Factors; Treatment Outcome; Triglycerides | 2013 |
Cholesterol-Lowering Effect of Calcium Alginate in Rats.
Topics: Alginates; Animals; Cholesterol; Dietary Fats; Dose-Response Relationship, Drug; Epichlorohydrin; Glucuronic Acid; Hexuronic Acids; Hypercholesterolemia; Hypolipidemic Agents; Imidazoles; Lipid Metabolism; Male; Random Allocation; Rats; Rats, Wistar; Resins, Synthetic; Specific Pathogen-Free Organisms | 2016 |
Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia.
Topics: Aged; Atorvastatin; Blood Glucose; Comorbidity; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Glycated Hemoglobin; Heptanoic Acids; Humans; Hypercholesterolemia; Hypoglycemic Agents; Imidazoles; Lipids; Male; Middle Aged; Multivariate Analysis; Pravastatin; Pyrroles; Quinolines; Resins, Synthetic; Retrospective Studies; Treatment Outcome | 2011 |
Early intervention with atorvastatin modulates TH1/TH2 imbalance in patients with acute coronary syndrome: from bedside to bench.
Topics: Acute Disease; Angina Pectoris; Angina, Unstable; Anion Exchange Resins; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Atorvastatin; CD4 Lymphocyte Count; Coronary Disease; Epichlorohydrin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Imidazoles; Immunophenotyping; Male; Prospective Studies; Pyrroles; Resins, Synthetic; Th1 Cells; Th2 Cells | 2004 |
Effects of colestimide on blood glucose-lowering activity and body weight in patients with type 2 diabetes and hypercholesterolemia.
Topics: Anion Exchange Resins; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Epichlorohydrin; Humans; Hypercholesterolemia; Imidazoles; Lipids; Resins, Synthetic | 2007 |
Colestimide lowers plasma glucose levels and increases plasma glucagon-like PEPTIDE-1 (7-36) levels in patients with type 2 diabetes mellitus complicated by hypercholesterolemia.
Topics: Anion Exchange Resins; Blood Glucose; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Glucagon-Like Peptide 1; Humans; Hypercholesterolemia; Imidazoles; Lipids; Male; Middle Aged; Resins, Synthetic | 2007 |
Lack of relationship between blood glucose-lowering activity of colestimide and serum cholecystokinin (CCK) concentrations in patients with type 2 diabetes.
Topics: Aged; Anion Exchange Resins; Blood Glucose; Cholecystokinin; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Humans; Hypercholesterolemia; Imidazoles; Male; Resins, Synthetic | 2008 |